Guest: Ali Djalilian, MD Ali Djalilian, MD is a cornea specialist and a clinician-scientist. He is the Searls-Schenk Professor of Ophthalmology at University of Illinois at Chicago. He completed fellowships with Dr Edward Holland at Cincinnati Eye Institute and at the National Eye Institute. He has an active clinical interest in limbal stem cell disease, …
Aniridia North America (ANA) announces its biennial scientific event to strengthen and expand research focused on aniridia and related problems. The 2025 Aniridia North America Symposium: PAX6, Aniridia, and Beyond will bring together top researchers from around the world for the presentation and discussion of innovative and often unpublished research at the forefront of understanding …
ANA desires to increase collaboration internationally and serve as a collective voice of North American stakeholders to the international aniridia community. In pursuit of that vision, representatives from ANA were honored to be invited to and to participate in the 7th European Aniridia Conference, hosted by Aniridia Sweden, together with Linkoping University and Aniridia Europe. The …
Thank you for your interest in furthering aniridia research by filling out the Aniridia and Neuropsychology survey. Below are the answers to Frequently Asked Questions about this survey. What is “Neuropsychology?” Neuropsychology is the study of the relationship between behavior, emotion, and the mind and their relationship to the central nervous system (the brain and spinal cord). …
What is the 2023 ANA Symposium? Who will attend? What is the format? These questions and more are answered here in the FAQs.
An article was recently published in the journal Clinical Ophthalmology regarding a new study comparing the visual acuity in aniridia vs. WAGR syndrome. Here is a plain language summary of the article, with a link to the full article below. Topic Overview Visual function varies greatly among persons with aniridia. Historically, the factors that determine …
This Symposium was a forum for scientists and medical professionals to discuss their work with each other. The purpose of this overview is to share patient-relevant information from these discussions.
The recent creation of a new nonprofit organization, Aniridia North America (ANA), has been announced by its founding Board of Directors. Aniridia North America is a charitable organization created to represent, serve, and support the North American community of persons affected by aniridia and their families, patient advocacy organizations, and clinicians and scientists. ANA was …
The following notes were taken by Kelly Trout, BSN, RN, at the 2019 John F Anderson Symposium. Kelly is Director, Research and Medical Advocacy for the International WAGR Syndrome Association. Please note that many of the presentations involved “basic science” research on how the eye develops before and after birth, often using animal models, rather …
Aniridia North America
106 W. Calendar Ave
Suite 122
LaGrange, IL 60525
Aniridia North America is registered as a 501(c)(3) non-profit organization in the United States.
EIN: 86-2917141
